Top

European Archives of Psychiatry and Clinical Neuroscience

Published in:

01-08-2011 | Original Paper

The Inventory of Depressive Symptomatology (IDS-C₂₈) is more sensitive to changes in depressive symptomatology than the Hamilton Depression Rating Scale (HAMD₁₇) in patients with mild major, minor or subsyndromal depression

Authors: Isabella Helmreich, Stefanie Wagner, Roland Mergl, Antje-Kathrin Allgaier, Martin Hautzinger, Verena Henkel, Ulrich Hegerl, André Tadić

Published in: European Archives of Psychiatry and Clinical Neuroscience | Issue 5/2011

Abstract

Depression rating scales play a decisive role in the assessment of the severity of depression and the evaluation of the efficacy of antidepressant treatments. The Hamilton Depression Rating Scale (HAMD) is regarded as the ‘gold standard’; nevertheless, studies suggest that the Inventory of Depressive Symptomatology (IDS) is more sensitive to detect symptom changes. The aim of the present study was to investigate whether the IDS is more sensitive in detecting changes in depression symptoms in patients with mild major, minor or subsyndromal depression (MIND). Biweekly IDS-C₂₈ and HAMD₁₇ data from 340 patients of a 10-week randomized, placebo-controlled trial comparing the effectiveness of sertraline and cognitive-behavioural therapy in patients with MIND were analysed. We investigated sensitivity to change for both scales (1) from assessment-to-assessment, (2) in relation to depression severity level, and (3) in relation to DSM-IV depression criterion symptoms. The IDS-C₂₈ was more sensitive in detecting changes in depression symptomatology over the treatment course as well as for different severity levels, especially in patients with a low depression severity. It assesses the DSM-IV criteria more thoroughly, is better able to track the change of cognitive symptoms and to identify residual symptoms. Both scales are well able to assess depressive symptomatology. However, the IDS-C₂₈ surpasses the HAMD₁₇ in detecting small changes especially in the core symptoms of depression. This is important for an optimal treatment by capturing early improvements, enabling prompt reactions and detecting residual symptoms.

Available only for authorised users

American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, Washington DC

American Psychiatric Association (APA) (2000) Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 157(suppl. 4):1–45

Bagby M, Ryder AG, Schuller DR, Marshall MB (2004) The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 161:2163–2177PubMedCrossRef

Bech P, Rafaelsen OJ (1980) The use of rating scales exemplified by a comparison of the Hamilton and the Bech Rafaelsen Melancholia scale. Acta Psychiatr Scand 62:128–131CrossRef

Bech P, Allerup P, Gram LF, Reisby N, Rosenberg R, Jacobsen O, Nagy A (1981) The Hamilton depression scale. Evaluation of objectivity using logistic models. Acta Psychiatr Scand 63:290–299PubMedCrossRef

Bech P, Allerup P, Reisby N, Gram LF (1984) Assessment of symptom change from improvement curves on the Hamilton depression scale in trials with antidepressants. Psychopharmacology 84:276–281PubMedCrossRef

Bech P, Stage KB, Nair NP, Larsen JK, Kragh-Sorensen P, Gjerris A (1997) The Major Depression Rating Scale (MDS). Inter-rater reliability and validity across different settings in randomized moclobemide trials. J Affect Disord 42:39–48PubMedCrossRef

Drieling T, Schärer LO, Langosch JM (2007) The Inventory of Depressive Symptomatology: German translation and psychometric validation. Int J Methods Psychiatr Res 16:230–236PubMedCrossRef

Entsuah R, Shaffer M, Zhang J (2002) A critical examination of the sensitivity of unidimensional subscales derived from the Hamilton Depression Rating Scale to antidepressant drug effects. J Psychiatr Res 36:437–448PubMedCrossRef

10.

Evans KR, Sills T, DeBrota DJ, Gelwicks S, Engelhardt N, Santor D (2004) An item response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies. J Psychiatr Res 38:275–284PubMedCrossRef

11.

Faries D, Herrera J, Rayamajhi J, DeBrota D, Demitrack M, Potter WZ (2000) The responsiveness of the Hamilton Depression Rating Scale. J Psychiatr Res 34:3–10PubMedCrossRef

12.

Fava GA, Rafanelli C, Grandi S, Canestrari R, Morphy M (1998) A six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry 155:1443–1445PubMed

13.

Feiger AD, Bielski RJ, Bremner J, Heiser JF, Trivedi M, Wilcox CS, Roberts DL, Kensler TT, McQuade RD, Kaplita SB, Archibald DG (1999) Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depression. Int Clin Psychopharmacol 14:19–28PubMedCrossRef

14.

Guillon CM, Rush AJ (1998) Toward a generalizable model of symptoms in major depressive disorder. Biol Psychiatry 44:959–972CrossRef

15.

Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62PubMedCrossRef

16.

Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278–296PubMedCrossRef

17.

Hegerl U, Hautzinger M, Mergl R, Kohnen R, Schütze M, Scheunemann W, Allgaier A-K, Coyne J, Henkel V (2010) Effects of pharmaco- and psychotherapy in depressed primary care patients. A randomized, controlled trial including a patient choice arm. Int J Neuropsychopharmacol 13:31–44PubMedCrossRef

18.

Howland RH, Schettler PJ, Rapaport MH, Mischoulon D, Schneider T, Fasiczka A, Delrahiem K, Maddux R, Lightfoot M, Nierenberg AA (2008) Clinical features and functioning of patients with minor depression. Psychother Psychosom 77:384–389PubMedCrossRef

19.

Iannuzzo R, Jaeger J, Goldberg J, Kafantaris V, Subletteet M (2006) Development and reliability of the HAM-D/MADRS interview: an integrated depression symptom rating scale. Psychiat Res 145:21–37CrossRef

20.

Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Paulus MP, Kunovac JL, Leon AC, Mueller TI, Rice JA, Keller MB (1998) A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 55:694–700PubMedCrossRef

21.

Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Paulus MP, Kunovac JL, Leon AC, Mueller TI, Rice JA, Keller MB (1998) Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 50:97–108PubMedCrossRef

22.

Judd LL, Paulus MJ, Schettler PJ, Akiskal HS, Endicott J, Leon AC, Maser JD, Mueller T, Solomon DA, Keller MB (2000) Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 157:1501–1504PubMedCrossRef

23.

Judd LL, Rapaport MH, Yonkers KA, Rush AJ, Frank E, Thase ME, Kupfer DJ, Plewes JM, Schettler PJ, Tollefson G (2004) Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. Am J Psychiatry 161:1864–1871PubMedCrossRef

24.

Lauge N, Behnke K, Søgaard J, Bahr B, Bech P (1998) Responsiveness of observer rating scales by analysis of number of days until improvement in patients with major depression. Eur Psychiatry 13:143–145PubMedCrossRef

25.

Maier W (1990) The Hamilton depression scale and its alternatives: a comparison of their reliability and validity. In: Bech P, Coppen A (eds) The Hamilton scales. Springer, Berlin, pp 64–71

26.

Miller IW, Keitner GI, Schatzberg AF, Klein DN, Thase ME, Rush AJ, Markowitz J, Schlager DS, Kornstein SG, Davis SM, Harrison WM, Keller MB (1998) The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry 59:608–619PubMedCrossRef

27.

Möller H-J (2001) Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale. Eur Arch Psychiatry Clin Neurosci 251(suppl. 2):13–20CrossRef

28.

Montgomery SA, Åsberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389PubMedCrossRef

29.

National Institute for Health, Clinical Excellence (2009) Depression: the treatment and management of depression in adults. National Clinical Practice Guideline 90. National Institute for Health and Clinical Excellence, London

30.

Paykel ES (1990) The use of the Hamilton Depression Scale in general practice. In: Bech P, Coppen A (eds) The Hamilton Scales. Springer, Berlin, pp 40–48

31.

Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, Jenaway A, Cornwall PL, Hayhurst H, Abbott R, Pope M (1999) Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry 56:829–835PubMedCrossRef

32.

Rapaport MH, Judd LL, Schettler PJ, Yonders KA, Thase ME, Kupfer DJ, Frank E, Plewes JM, Tollefson GD, Rush AJ (2002) A descriptive analysis of minor depression. Am J Psychiatry 159:637–643PubMedCrossRef

33.

Rehm LP, O′Hara MW (1985) Item characteristics of the Hamilton rating scale for depression. J Psychiat Res 19:31–41PubMedCrossRef

34.

Rush AJ, Gilles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C (1986) The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 18:65–87PubMedCrossRef

35.

Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi HM (1996) The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 26:477–486PubMedCrossRef

36.

Rush AJ, Carmody TJ, Reimitz PE (2000) The Inventory of Depressive Symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. Int J Methods Psychiatr Res 9:45–59CrossRef

37.

Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB (2003) The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 54:573–583PubMedCrossRef

38.

Rush AJ, Carmody TJ, Ibrahim HM, Trivedi HM, Biggs MM, Shores-Wilson K, Crismon ML, Toprac MG, Kashner TM (2006) Comparison of self-report and clinician ratings on two inventories of depressive symptomatology. Psychiatr Serv 57:826–837CrossRef

39.

Thase ME, Simons AD, McGeary J, Cahalane JF, Hughes C, Harden T, Friedman E (1992) Relapse after cognitive behaviour therapy of depression: potential implications for longer courses of treatment. Am J Psychiatry 149:1046–1052PubMed

40.

Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, Witte B, Kashner TM (2004) The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self Report (IDS-SR) and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 34:73–82PubMedCrossRef

41.

Vittengl JR, Clark LA, Kraft D, Jarrett R (2005) Multiple measures, methods, and moments: a factor-analytic investigation of change in depressive symptoms during acute-phase cognitive therapy for depression. Psychol Med 35:693–704PubMedCrossRef

42.

Wagner S, Helmreich I, Lieb K, Tadić A (2011) Standardized rater training for the Hamilton Depression Rating Scale (HAMD₁₇) and the Inventory of Depressive Symptoms (IDS_C30). Psychopathology 44:68–70. doi:10.1159/000318162)

43.

Williams JBW (1988) A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry 45:742–747PubMed

44.

Williams JBW (2001) Standardizing the Hamilton Depression Rating Scale: past, present, and future. Eur Arch Psychiatry Clin Neurosci 251(suppl 2):6–12CrossRef

45.

Wittchen H-U, Pfister H (eds) (1997) DIA-X-interview. Instruktionsmanual zur Durchführung von DIA-X Interviews. Swets & Zeitlinger, Frankfurt am Main

46.

World Health Organization (WHO) (1993) Composite international diagnostic interview, version 1.1. World Health Organization, Geneva

47.

Yang H, Chuzi S, Sinicropi-Yao L, Johnson D, Chen Y, Clain A, Baer L, McGrath PJ, Stewart JW, Fava M, Papakostas GI (2010) Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine. Eur Arch Psychiatry Clin Neurosci 260:145–150PubMedCrossRef

Title: The Inventory of Depressive Symptomatology (IDS-C28) is more sensitive to changes in depressive symptomatology than the Hamilton Depression Rating Scale (HAMD17) in patients with mild major, minor or subsyndromal depression
Authors: Isabella Helmreich
Stefanie Wagner
Roland Mergl
Antje-Kathrin Allgaier
Martin Hautzinger
Verena Henkel
Ulrich Hegerl
André Tadić
Publication date: 01-08-2011
Publisher: Springer-Verlag
Published in: European Archives of Psychiatry and Clinical Neuroscience / Issue 5/2011
Print ISSN: 0940-1334
Electronic ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-010-0175-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Inventory of Depressive Symptomatology (IDS-C₂₈) is more sensitive to changes in depressive symptomatology than the Hamilton Depression Rating Scale (HAMD₁₇) in patients with mild major, minor or subsyndromal depression

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2011

Predictors of clinical and social outcomes following involuntary hospital admission: a prospective observational study

Expressed and perceived emotion over time: does the patients’ view matter for the caregivers’ burden?

Different gray matter patterns in chronic schizophrenia and chronic bipolar disorder patients identified using voxel-based morphometry

BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects

Decreasing the minimum length criterion for an episode of hypomania: evaluation using self-reported data from patients with bipolar disorder

The N1 auditory evoked potential component as an endophenotype for schizophrenia: high-density electrical mapping in clinically unaffected first-degree relatives, first-episode, and chronic schizophrenia patients